| Company | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| Forma Therapeutics Holdings, Inc. | SVP, Commercial Officer | Common Stock | 0 | $5.05 | 14 Oct 2022 | Direct | |
| Forma Therapeutics Holdings, Inc. | SVP, Commercial Officer | Stock Option (Right to Buy) | 0 | 14 Oct 2022 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Role | Filing Time |
|---|---|---|---|---|---|---|---|
| /report/000089924322033661-lesser-brian-andrew-2022-10-14 | Forma Therapeutics Holdings, Inc. | 14 Oct 2022 | 8 | $0 | 4 | SVP, Commercial Officer | 14 Oct 2022, 16:07 |
| /report/000089924322008634-lesser-brian-andrew-2022-02-28 | Forma Therapeutics Holdings, Inc. | 28 Feb 2022 | 2 | $0 | 4 | SVP, Commercial | 02 Mar 2022, 16:10 |
| /report/000089924322007912-lesser-brian-andrew-2022-02-23 | Forma Therapeutics Holdings, Inc. | 23 Feb 2022 | 1 | -$37,516 | 4 | SVP, Commercial | 25 Feb 2022, 16:02 |
| /report/000089924322031455-lesser-brian-andrew-2021-11-15-restatement | Forma Therapeutics Holdings, Inc. | 15 Nov 2021 | 0 | $0 | 3/A | SVP, Commercial | 19 Sep 2022, 16:05 |